NARAYANA HRUDAYALAYA share price has zoomed 3% and is presently trading at Rs 1,221.0.
Meanwhile, the BSE HEALTHCARE index is at 36,807.4 (up 0.3%).
Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 6.5%) and MAX HEALTHCARE INSTITUTE (up 4.9%).
ALEMBIC PHARMA (down 1.8%) and KIMS (down 1.8%) are among the top losers today.
Over the last one year, NARAYANA HRUDAYALAYA has moved up from Rs 1,010.6 to Rs 1,221.0, registering a gain of Rs 210.4 (up 20.8%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,266.1 to 36,807.4, registering a gain of 45.7% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 89.7%), Glenmark Pharma (up 89.4%) and GSK Pharma (up 83.9%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 78,904.8 (up 0.3%).
The top gainers among the BSE Sensex today are Ultratech Cement (up 2.9%) and JSW Steel (up 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and M&M.
In the meantime, NSE Nifty is at 23,919.1 (up 0.2%). Ultratech Cement and JSW Steel are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 62,970.0 to 78,904.8, registering a gain of 15,934.8 points (up 25.3%).
NARAYANA HRUDAYALAYA net profit grew 10.1% YoY to Rs 1,908 million for the quarter ended March 2024, compared to a profit of Rs 1,732 million a year ago. Net sales rose 4.7% to Rs 12,794 million during the period as against Rs 12,216 million in January-March 2023.
For the year ended March 2023, NARAYANA HRUDAYALAYA reported 77.3% increase in net profit to Rs 6,066 million compared to net profit of Rs 3,421 million during FY22. Revenue of the company grew 22.2% to Rs 45,248 million during FY23.
The current Price to earnings ratio of NARAYANA HRUDAYALAYA, based on rolling 12 month earnings, stands at 31.6.
Equitymaster requests your view! Post a comment on "NARAYANA HRUDAYALAYA Gains 3%; BSE HEALTHCARE Index Up 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!